Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Diagnos Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by scorpio40on Oct 05, 2017 10:26am
95 Views
Post# 26780177

RE:RE:RE:RE:RE:real analyst coverage when?????

RE:RE:RE:RE:RE:real analyst coverage when?????Here is a copy of the email I just sent to the so-called analyst - 'tammie.asher@simplywallst.com'

Ms. Asher,
 
The information contained in your research report is misleading and completely out of date. If you are serious about being ‘extremely devoted to educating novice investors on sound investment principles’ may I suggest that you visit their website www.diagnos.ca , follow the links to read what the real story is https://www.stockhouse.com/opinion/independent-reports/2017/09/21/diagnos-inc-expands-artificial-intelligence-platform-first-mover-$386-billion-yr and also https://technologymarketwatch.com/adk.htm then take the time and call the president Mr. Andre Larente at 450-678-8882 ext. 224
Email: alarente@diagnos.ca
.
 
https://simplywall.st/news/2017/10/05/will-you-be-burnt-by-diagnos-incs-tsxvadk-cash-burn/
 
Hopefully you will update the information on your site to truly reflect the enormous potential of their cutting-edge technology.



scorp
 



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities